Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Hôpital Européen Georges-Pompidou
París, FranciaPublications in collaboration with researchers from Hôpital Européen Georges-Pompidou (23)
2024
-
A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet
Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 67-75
-
A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride
Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 57-65
-
Acyl-CoA binding protein for the experimental treatment of anorexia
Science translational medicine, Vol. 16, Núm. 760, pp. eadl0715
-
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
Clinical Lung Cancer, Vol. 25, Núm. 3, pp. 233-243.e8
-
Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics
Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 199-209
-
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831
-
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide
Cell Death and Disease, Vol. 15, Núm. 4
-
Orthotopic Model of Hepatocellular Carcinoma in Mice
Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 1-13
-
Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer
Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 189-198
2023
-
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53
-
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Lung Cancer, Vol. 178, pp. 116-122
2021
-
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week
Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 922-936
-
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data
BMJ, Vol. 375
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Prospective follow-up in various subtypes of cardiomyopathies: Insights from the ESC EORP Cardiomyopathy Registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 7, Núm. 2, pp. 134-142
2018
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076
2017
-
Cardiac allograft vasculopathy
The Pathology of Cardiac Transplantation: A Clinical and Pathological Perspective (Springer International Publishing), pp. 279-305
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology
European Heart Journal, Vol. 37, Núm. 2, pp. 164-173
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222